000 01136 a2200325 4500
005 20250514184404.0
264 0 _c20040507
008 200405s 0 0 ger d
022 _a0048-3664
024 7 _a10.1002/pauz.200400062
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLadetzki-Baehs, Kathrin
245 0 0 _a[On asthma and allergic reactions. Omalizumab: from IgE to anti-IgE].
_h[electronic resource]
260 _bPharmazie in unserer Zeit
_c2004
300 _a116-22 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Anti-Idiotypic
650 0 4 _aAntibodies, Monoclonal
_xpharmacology
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAsthma
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aHypersensitivity
_xdrug therapy
650 0 4 _aImmunoglobulin E
_ximmunology
650 0 4 _aOmalizumab
700 1 _aDirsch, Verena M
700 1 _aVollmar, Angelika M
773 0 _tPharmazie in unserer Zeit
_gvol. 33
_gno. 2
_gp. 116-22
856 4 0 _uhttps://doi.org/10.1002/pauz.200400062
_zAvailable from publisher's website
999 _c14797113
_d14797113